Measure financial year 2016/17 | |
1 | Number of patients with cancer that have their care overseen by an MDT by stage of disease, for lung, ovarian, rectal and liver cancer. |
2 | Number of patients with lung cancer that have their care overseen by an MDT prior to commencement of any treatment modality by stage of disease. |
3 | Number of times that Medicare Benefits Schedule (MBS) billing has occurred to support MDT activity. |
4 | Proportion of patients for whom documentation of their planned treatment is sent to the patients’ General Practitioner (GP) within 7 days of MDT/or any other time measure point along the treatment pathway. |
Measure financial year 2017/18 and 18/19 | |
1 | Proportion of multidisciplinary teams listed on Canrefer within the Local Health District that have data updated every 6 months within 4 weeks of receipt of request to update. |
2 | Number of new primary lung cancer patients by stage of disease that are presented at an MDT prior to commencement of any treatment modality. |
3 | Proportion of MDTs using MBS billing in the Local Health District. |
4 | Local Health District capability for MBS billing for MDTs. |
5 | Proportion of patients presented at MDT where a discussion summary is then sent to the GP. |
6 | Median timeframe from MDT to GP communication. |